Demirtas CO - Search Results

1

Programmed Cell Death 1 and Hepatocellular Carcinoma: An Epochal Story.

Demirtas CO, Gunduz F. Demirtas CO, et al. J Gastrointest Cancer. 2021 Dec;52(4):1217-1222. doi: 10.1007/s12029-021-00758-z. Epub 2021 Dec 11. J Gastrointest Cancer. 2021. PMID: 34897577 Review.

2

Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.

Demirtas CO, Gunduz F, Tuney D, Baltacioglu F, Kani HT, Bugdayci O, Alahdab YO, Ozdogan OC. Demirtas CO, et al. Eur J Gastroenterol Hepatol. 2020 Apr;32(4):517-523. doi: 10.1097/MEG.0000000000001528. Eur J Gastroenterol Hepatol. 2020. PMID: 31524775

3

External validation of the Toronto hepatocellular carcinoma risk index in Turkish cirrhotic patients.

Demirtas CO, Gunduz F, Kani HT, Keklikkiran C, Alahdab YO, Yilmaz Y, Duman DG, Atug O, Giral A, Aslan R, Cagatay NS, Ozkan B, Ozdogan OC. Demirtas CO, et al. Eur J Gastroenterol Hepatol. 2020 Jul;32(7):882-888. doi: 10.1097/MEG.0000000000001685. Eur J Gastroenterol Hepatol. 2020. PMID: 32395972

4

Evaluation of the Association between Programmed Cell Death-1 Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects. A Pilot Study.

Demirci AF, Demirtas CO, Eren F, Yilmaz D, Keklikkiran C, Ozdogan OC, Gunduz F. Demirci AF, et al. Among authors: demirtas co. J Gastrointestin Liver Dis. 2020 Oct 27;29(4):617-622. doi: 10.15403/jgld-2623. J Gastrointestin Liver Dis. 2020. PMID: 33118543 Free article.

5

Letter: Is female sex an independent predictor of favourable prognosis in hepatocellular carcinoma?

Demirtas CO, Gunduz F. Demirtas CO, et al. Aliment Pharmacol Ther. 2020 Dec;52(11-12):1765-1766. doi: 10.1111/apt.16088. Aliment Pharmacol Ther. 2020. PMID: 33205876 No abstract available.

6

Recommendations for Reopening Endoscopy Units in Turkey: A Set-up Plan from a Tertiary Center in Istanbul.

Demirtas CÖ, Keklikkıran Ç, Mehdiyev S, Ergenç İ, Özen Alahdab Y, Gündüz F, Yılmaz Y, Atuğ Ö, Özdoğan OC. Demirtas CÖ, et al. Turk J Gastroenterol. 2021 Feb;32(2):113-115. doi: 10.5152/tjg.2021.20434. Turk J Gastroenterol. 2021. PMID: 33960933 Free PMC article.

7

Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study.

Demirtaş CÖ, Tolu T, Keklikkıran Ç, Özdoğan OC, Gündüz F. Demirtaş CÖ, et al. Turk J Gastroenterol. 2021 Aug;32(8):685-693. doi: 10.5152/tjg.2021.20677. Turk J Gastroenterol. 2021. PMID: 34528882 Free PMC article.

8

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?

Demirtas CO, Brunetto MR. Demirtas CO, et al. World J Gastroenterol. 2021 Sep 7;27(33):5536-5554. doi: 10.3748/wjg.v27.i33.5536. World J Gastroenterol. 2021. PMID: 34588750 Free PMC article. Review.

9

Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders.

Demirtas CO, Ricco G, Ozdogan OC, Baltacioglu F, Ones T, Yumuk PF, Dulundu E, Uzun S, Colombatto P, Oliveri F, Brunetto MR, Gunduz F. Demirtas CO, et al. Hepatol Commun. 2022 Mar;6(3):633-645. doi: 10.1002/hep4.1836. Epub 2021 Nov 9. Hepatol Commun. 2022. PMID: 34751001 Free PMC article.

10

Surveillance Strategies for Hepatocellular Carcinoma: Recent Advances and the Shifting Paradigm.

Demirtas CO, Gunduz F, Ozdogan OC. Demirtas CO, et al. J Gastrointest Cancer. 2021 Dec;52(4):1336-1339. doi: 10.1007/s12029-021-00755-2. Epub 2021 Dec 2. J Gastrointest Cancer. 2021. PMID: 34855124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters